ImmunityBio Inc (NASDAQ:IBRX) currently has a daily average trading volume of 8.94M but it saw 6401763 shares traded in last market. With a market cap of 2.43B USD, the company’s current market price of $2.75 came rising about 0.36 while comparing to the previous closing price of $2.74. In past 52 weeks, the stock remained buoying in the range of price level as high as $7.48 and as low as $1.83. In the recent trading on the day, stock has struck highest price mark of $2.71 while lowest mark touched by it was $2.82.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Piper Sandler which upgraded the stock as “Overweight” in its note to investors issued on May 20, 2025, recommending a price target of $5 for it. BTIG Research issued its recommendations for the stock as it initiated the price target for the stock is $6.
Over the week, IBRX’s stock price is moving -1.43% down while it is -10.42% when we observe its performance for the past one month. Year-to-date it is -58.46% down and over the past year, the stock is showing an upside performance of 7.42%.
Currently, ImmunityBio Inc’s total number of outstanding shares is 853.39M with 74.11% of that held by the insiders while 9.24% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -182.90%. Stock’s beta reads 0.02. Stock has a price to sale or P/S ratio amounts to 77.75. Its return on asset (ROA) is -116.15% on average.
